FMC updates Q3 guidance; large pricing charges and impairment risk evident
Oct 15, 2026, 7:44 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Large upcoming charges and impairment risk create near-term earnings pressure; although actions aim to improve long-term channel health, the initial financial delta is negative.
AI summary
What happened, with direct paths to the underlying reporting
FMC cut third-quarter guidance to $65–$125 million in revenue and projected -$510 million to -$565 million in Adjusted EBITDA, reflecting $625–$675 million of charges from new commercial actions. The plan includes broad-based price reductions in Brazil, Argentina, the US and Canada and a US pricing-model overhaul to hasten product movement. The firm aims to improve channel health and unlock replenishment demand ahead of 2027.
Q3 revenue guidance: $65M–$125M; Adjusted EBITDA: -$510M to -$565M.
Commercial actions add $625M–$675M charges; pricing changes in US and LATAM.
Impairment assessment triggered as of Sept 30, 2026; magnitude uncertain.
Earnings call set for Oct 29–30, 2026; covenant discussions with banks anticipated.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
FMC faces near-term price risk as two major banks cut price targets ahead of the company’s Q3 earnings on Oct 29. The stock offers a 3.34% dividend yield, but analysts’ cuts may c…
FMC Corp announced better-than-expected second-quarter financial results and reaffirmed its fiscal year 2026 guidance, indicating strong confidence in its future performance. This…
FMC lowered FY2025 earnings and sales guidance, reflecting challenging market conditions. Third-quarter sales dropped 49% year-over-year, severely impacted by India. New active in…